This is an archived document. The links are no longer being updated.
TB Notes 2, 2001
New CDC Publications
Driscoll JR, Lee PA, Jovell RJ, Hale YM, Salfinger M. How and why
we fingerprint tuberculosis. RT, The Journal for Respiratory
Care Practitioners 2001;14(1).
Lan NTN, Iademarco MF, Binkin NJ, Tung LB, Quy HT, Co NV. A case
series: initial outcome of persons with multidrug-resistant tuberculosis
after treatment with the WHO standard re-treatment regimen in Ho
Chi Minh City, Vietnam. Int J Tuberc Lung Dis 2001;5(6):575-578.
Laserson KF, Kenyon AS, Layloff TA, Binkin NJ. Substandard tuberculosis
drugs on the global market and their simple detection. Int J
Tuberc Lung Dis 2001;5(5):448-454.
O’Brien RJ, Nunn PP. The need for new drugs against tuberculosis:
obstacles, opportunities, and the next steps. Am J Respir Crit
Care Med 2001; 162:1055-1058.
Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb
Please send comments/suggestions/requests
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333